eFFECTOR Therapeutics, Inc. (EFTR) Tops Q1 EPS by 84c
Tweet
Share
E-mailGet Alerts EFTR Hot Sheet
Join SI Premium – FREE
eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) reported Q1 EPS of ($2.16), $0.84 better than the analyst estimate of ($3.00).
For earnings history and earnings-related data on eFFECTOR Therapeutics, Inc. (EFTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Reading (RDI) Tops Q2 EPS by 4c
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
